This profile has not been verified yet. Information presented here may thus be incomplete or inaccurate.
The 44 Channel Suprachoroidal Retinal Prosthesis is a second generation device boasting a higher electrode array and larger field of view than the first generation device launched by Bionic Vision Technologies. Since launching a 4-patient clinical trial in 2018, the results have indicated that the device offers functional benefits to patients while providing a safe and reproducible surgical procedure.
Commercial Partner
Milestones
- 2018: First patient implanted
Device Specifications
- Number of electrodes: 44
Clinical Trials
Article Information
April 16, 2024 21:45 PM
The following people contributed to this page:
Quick Links
Contact Us
This is a community project. Find out more about our team of contributors. If you'd like to contribute, please contact us.
Media Copyright Information
All images used with permission. Introduction graphic: © Getty. Background graphic: © Tracy Spohn/Shutterstock.
Made with at UC Santa Barbara, with generous support from the bionic vision community (2020—2024).
All our content (unless otherwise noted) is licensed under CC-BY 4.0.